CVE-2023-53734 is a critical SQL injection vulnerability in dawa-pharma-1.0, allowing unauthenticated attackers to execute arbitrary SQL queries. With a CVSS score of 8.7 (HIGH), this vulnerability is easily exploitable over the network with low attack complexity, potentially leading to sensitive data exposure and administrative access. While there is no evidence of active exploitation, nor publicly available exploit code, its high FAUCET Risk Score of 90/100 indicates significant potential impact. Community discussion and media coverage for this CVE are currently minimal.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
| Mayurik | Dawa-Pharma | 1.0-2022CNA affecteddefault unaffected |
CVSS version used by this source: 4.0
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
The average CVE in this peer group has 0.0 Twitter, 0.0 Reddit, 0.1 Bluesky, 0.1 Mastodon, and 0.4 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.1 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.